AptaBio Therapeutics
Giheung
About AptaBio Therapeutics
AptaBio Therapeutics is a pharmaceutical biotechnology company that develops intractable innovative drugs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $28.6M
- Funding stage: Early Stage Venture
- Last round: Series B (May 2018)
- Website: aptabio.com
- Phone: +82 31-365-3693
Industries & Categories
Biotechnology, Health Care, Medical, Pharmaceutical
Canonical: https://fsome.com/organization/aptabio-therapeutics-49940 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.